secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0000310764-26-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker reports Q4 2025 sales $7.2B, +11% organic; 2026 outlook 8-9.5% organic growth
--------------------------------------------------------------------------------

- Q4 reported EPS $2.20 (+56% YoY); adjusted EPS $4.47 (+11.5%).
- Full year net sales $25.1B (+11.2% reported); organic growth 10.3%.
- MedSurg & Neurotechnology Q4 organic sales +12.6%; Orthopaedics +8.4% organic.
- Adjusted operating margin expanded 100 bps to 30.2% in Q4, 26.3% full year.
- 2026 guidance: organic sales growth 8.0%-9.5%; adjusted EPS $14.90-$15.10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076426000006/0000310764-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076426000006/syk-20260129.htm
  HTML page:      https://secwatch.observer/filing/0000310764-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer